nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—hypertension—type 2 diabetes mellitus	0.573	1	CtDrD
Acebutolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0539	0.206	CbGbCtD
Acebutolol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0329	0.125	CbGbCtD
Acebutolol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0293	0.112	CbGbCtD
Acebutolol—SLC22A1—Metformin—type 2 diabetes mellitus	0.0215	0.0819	CbGbCtD
Acebutolol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0212	0.0809	CbGbCtD
Acebutolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.02	0.0762	CbGbCtD
Acebutolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0184	0.0703	CbGbCtD
Acebutolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0151	0.0577	CbGbCtD
Acebutolol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0146	0.0556	CbGbCtD
Acebutolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0145	0.0554	CbGbCtD
Acebutolol—ABCB1—Glyburide—type 2 diabetes mellitus	0.0109	0.0414	CbGbCtD
Acebutolol—ABCB1—Losartan—type 2 diabetes mellitus	0.00993	0.0379	CbGbCtD
Acebutolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000644	0.313	CrCbGaD
Acebutolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000554	0.269	CrCbGaD
Acebutolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000302	0.147	CrCbGaD
Acebutolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000244	0.118	CrCbGaD
Acebutolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000156	0.0758	CrCbGaD
Acebutolol—Propranolol—CYP1A2—type 2 diabetes mellitus	9.5e-05	0.0462	CrCbGaD
Acebutolol—Discomfort—Metformin—type 2 diabetes mellitus	9.35e-05	0.000767	CcSEcCtD
Acebutolol—Fatigue—Gliclazide—type 2 diabetes mellitus	9.35e-05	0.000767	CcSEcCtD
Acebutolol—Nausea—Glipizide—type 2 diabetes mellitus	9.32e-05	0.000765	CcSEcCtD
Acebutolol—Vomiting—Glimepiride—type 2 diabetes mellitus	9.31e-05	0.000764	CcSEcCtD
Acebutolol—Hypotension—Valsartan—type 2 diabetes mellitus	9.31e-05	0.000764	CcSEcCtD
Acebutolol—Vision blurred—Losartan—type 2 diabetes mellitus	9.31e-05	0.000763	CcSEcCtD
Acebutolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.29e-05	0.000761	CcSEcCtD
Acebutolol—Constipation—Gliclazide—type 2 diabetes mellitus	9.28e-05	0.000761	CcSEcCtD
Acebutolol—Pain—Gliclazide—type 2 diabetes mellitus	9.28e-05	0.000761	CcSEcCtD
Acebutolol—Rash—Glimepiride—type 2 diabetes mellitus	9.24e-05	0.000757	CcSEcCtD
Acebutolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.23e-05	0.000757	CcSEcCtD
Acebutolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000756	CcSEcCtD
Acebutolol—Rash—Sitagliptin—type 2 diabetes mellitus	9.21e-05	0.000755	CcSEcCtD
Acebutolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.2e-05	0.000754	CcSEcCtD
Acebutolol—Headache—Glimepiride—type 2 diabetes mellitus	9.18e-05	0.000752	CcSEcCtD
Acebutolol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.16e-05	0.000751	CcSEcCtD
Acebutolol—Cough—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000751	CcSEcCtD
Acebutolol—Headache—Sitagliptin—type 2 diabetes mellitus	9.15e-05	0.00075	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.08e-05	0.000745	CcSEcCtD
Acebutolol—Oedema—Metformin—type 2 diabetes mellitus	9.08e-05	0.000744	CcSEcCtD
Acebutolol—Tinnitus—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000744	CcSEcCtD
Acebutolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.04e-05	0.000741	CcSEcCtD
Acebutolol—Flushing—Ramipril—type 2 diabetes mellitus	9.03e-05	0.00074	CcSEcCtD
Acebutolol—Insomnia—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000739	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.97e-05	0.000736	CcSEcCtD
Acebutolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.95e-05	0.000734	CcSEcCtD
Acebutolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.94e-05	0.000733	CcSEcCtD
Acebutolol—Chest pain—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000733	CcSEcCtD
Acebutolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000733	CcSEcCtD
Acebutolol—Myalgia—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000733	CcSEcCtD
Acebutolol—Shock—Metformin—type 2 diabetes mellitus	8.93e-05	0.000732	CcSEcCtD
Acebutolol—Insomnia—Orlistat—type 2 diabetes mellitus	8.91e-05	0.00073	CcSEcCtD
Acebutolol—Malaise—Losartan—type 2 diabetes mellitus	8.91e-05	0.00073	CcSEcCtD
Acebutolol—Anxiety—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.00073	CcSEcCtD
Acebutolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	8.9e-05	0.00073	CcSEcCtD
Acebutolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000729	CcSEcCtD
Acebutolol—Vertigo—Losartan—type 2 diabetes mellitus	8.87e-05	0.000728	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000728	CcSEcCtD
Acebutolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.87e-05	0.000727	CcSEcCtD
Acebutolol—Somnolence—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000727	CcSEcCtD
Acebutolol—Syncope—Losartan—type 2 diabetes mellitus	8.86e-05	0.000726	CcSEcCtD
Acebutolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.84e-05	0.000725	CcSEcCtD
Acebutolol—Discomfort—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000724	CcSEcCtD
Acebutolol—Skin disorder—Metformin—type 2 diabetes mellitus	8.82e-05	0.000723	CcSEcCtD
Acebutolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.77e-05	0.000719	CcSEcCtD
Acebutolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.77e-05	0.000719	CcSEcCtD
Acebutolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000719	CcSEcCtD
Acebutolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.74e-05	0.000717	CcSEcCtD
Acebutolol—Palpitations—Losartan—type 2 diabetes mellitus	8.73e-05	0.000716	CcSEcCtD
Acebutolol—Nausea—Glimepiride—type 2 diabetes mellitus	8.7e-05	0.000713	CcSEcCtD
Acebutolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.68e-05	0.000712	CcSEcCtD
Acebutolol—Nausea—Sitagliptin—type 2 diabetes mellitus	8.67e-05	0.000711	CcSEcCtD
Acebutolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000711	CcSEcCtD
Acebutolol—Asthenia—Glyburide—type 2 diabetes mellitus	8.67e-05	0.000711	CcSEcCtD
Acebutolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	8.66e-05	0.00071	CcSEcCtD
Acebutolol—Anorexia—Metformin—type 2 diabetes mellitus	8.65e-05	0.000709	CcSEcCtD
Acebutolol—Cough—Losartan—type 2 diabetes mellitus	8.62e-05	0.000707	CcSEcCtD
Acebutolol—Urticaria—Gliclazide—type 2 diabetes mellitus	8.62e-05	0.000707	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.6e-05	0.000706	CcSEcCtD
Acebutolol—Alopecia—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000705	CcSEcCtD
Acebutolol—Fatigue—Valsartan—type 2 diabetes mellitus	8.59e-05	0.000705	CcSEcCtD
Acebutolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000703	CcSEcCtD
Acebutolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000703	CcSEcCtD
Acebutolol—Oedema—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000702	CcSEcCtD
Acebutolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	8.56e-05	0.000702	CcSEcCtD
Acebutolol—Pruritus—Glyburide—type 2 diabetes mellitus	8.55e-05	0.000701	CcSEcCtD
Acebutolol—Constipation—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000699	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.5e-05	0.000697	CcSEcCtD
Acebutolol—Fatigue—Orlistat—type 2 diabetes mellitus	8.49e-05	0.000696	CcSEcCtD
Acebutolol—Hypotension—Metformin—type 2 diabetes mellitus	8.48e-05	0.000695	CcSEcCtD
Acebutolol—Shock—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000691	CcSEcCtD
Acebutolol—Pain—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000691	CcSEcCtD
Acebutolol—Arthralgia—Losartan—type 2 diabetes mellitus	8.41e-05	0.000689	CcSEcCtD
Acebutolol—Chest pain—Losartan—type 2 diabetes mellitus	8.41e-05	0.000689	CcSEcCtD
Acebutolol—Myalgia—Losartan—type 2 diabetes mellitus	8.41e-05	0.000689	CcSEcCtD
Acebutolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.4e-05	0.000689	CcSEcCtD
Acebutolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000689	CcSEcCtD
Acebutolol—Anxiety—Losartan—type 2 diabetes mellitus	8.38e-05	0.000687	CcSEcCtD
Acebutolol—Rash—Bromocriptine—type 2 diabetes mellitus	8.33e-05	0.000683	CcSEcCtD
Acebutolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.33e-05	0.000683	CcSEcCtD
Acebutolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.000682	CcSEcCtD
Acebutolol—Discomfort—Losartan—type 2 diabetes mellitus	8.31e-05	0.000681	CcSEcCtD
Acebutolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000679	CcSEcCtD
Acebutolol—Headache—Bromocriptine—type 2 diabetes mellitus	8.28e-05	0.000679	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.27e-05	0.000678	CcSEcCtD
Acebutolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.27e-05	0.000678	CcSEcCtD
Acebutolol—Anorexia—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000669	CcSEcCtD
Acebutolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.15e-05	0.000668	CcSEcCtD
Acebutolol—Paraesthesia—Metformin—type 2 diabetes mellitus	8.15e-05	0.000668	CcSEcCtD
Acebutolol—Confusional state—Losartan—type 2 diabetes mellitus	8.13e-05	0.000666	CcSEcCtD
Acebutolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.12e-05	0.000665	CcSEcCtD
Acebutolol—Dyspnoea—Metformin—type 2 diabetes mellitus	8.09e-05	0.000663	CcSEcCtD
Acebutolol—Somnolence—Metformin—type 2 diabetes mellitus	8.07e-05	0.000662	CcSEcCtD
Acebutolol—Oedema—Losartan—type 2 diabetes mellitus	8.06e-05	0.000661	CcSEcCtD
Acebutolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.05e-05	0.00066	CcSEcCtD
Acebutolol—Hypotension—Irbesartan—type 2 diabetes mellitus	8e-05	0.000656	CcSEcCtD
Acebutolol—Dyspepsia—Metformin—type 2 diabetes mellitus	7.99e-05	0.000655	CcSEcCtD
Acebutolol—Shock—Losartan—type 2 diabetes mellitus	7.93e-05	0.00065	CcSEcCtD
Acebutolol—Urticaria—Valsartan—type 2 diabetes mellitus	7.92e-05	0.000649	CcSEcCtD
Acebutolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.91e-05	0.000648	CcSEcCtD
Acebutolol—Decreased appetite—Metformin—type 2 diabetes mellitus	7.89e-05	0.000647	CcSEcCtD
Acebutolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000646	CcSEcCtD
Acebutolol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000644	CcSEcCtD
Acebutolol—Nausea—Bromocriptine—type 2 diabetes mellitus	7.85e-05	0.000644	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.84e-05	0.000643	CcSEcCtD
Acebutolol—Fatigue—Metformin—type 2 diabetes mellitus	7.83e-05	0.000642	CcSEcCtD
Acebutolol—Urticaria—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000642	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.8e-05	0.00064	CcSEcCtD
Acebutolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.79e-05	0.000639	CcSEcCtD
Acebutolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000638	CcSEcCtD
Acebutolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000638	CcSEcCtD
Acebutolol—Asthenia—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.000638	CcSEcCtD
Acebutolol—Constipation—Metformin—type 2 diabetes mellitus	7.76e-05	0.000636	CcSEcCtD
Acebutolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000631	CcSEcCtD
Acebutolol—Anorexia—Losartan—type 2 diabetes mellitus	7.68e-05	0.00063	CcSEcCtD
Acebutolol—Vomiting—Glyburide—type 2 diabetes mellitus	7.68e-05	0.00063	CcSEcCtD
Acebutolol—Pruritus—Gliclazide—type 2 diabetes mellitus	7.68e-05	0.000629	CcSEcCtD
Acebutolol—Malaise—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000626	CcSEcCtD
Acebutolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000626	CcSEcCtD
Acebutolol—Rash—Glyburide—type 2 diabetes mellitus	7.62e-05	0.000625	CcSEcCtD
Acebutolol—Somnolence—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000624	CcSEcCtD
Acebutolol—Dermatitis—Glyburide—type 2 diabetes mellitus	7.61e-05	0.000624	CcSEcCtD
Acebutolol—Vertigo—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000624	CcSEcCtD
Acebutolol—Syncope—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000623	CcSEcCtD
Acebutolol—Headache—Glyburide—type 2 diabetes mellitus	7.57e-05	0.000621	CcSEcCtD
Acebutolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000618	CcSEcCtD
Acebutolol—Hypotension—Losartan—type 2 diabetes mellitus	7.53e-05	0.000618	CcSEcCtD
Acebutolol—Palpitations—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000614	CcSEcCtD
Acebutolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.48e-05	0.000613	CcSEcCtD
Acebutolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000611	CcSEcCtD
Acebutolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.44e-05	0.00061	CcSEcCtD
Acebutolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.42e-05	0.000609	CcSEcCtD
Acebutolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.42e-05	0.000609	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.39e-05	0.000606	CcSEcCtD
Acebutolol—Cough—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000606	CcSEcCtD
Acebutolol—Fatigue—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000606	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.34e-05	0.000602	CcSEcCtD
Acebutolol—Pain—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000601	CcSEcCtD
Acebutolol—Constipation—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000601	CcSEcCtD
Acebutolol—Insomnia—Losartan—type 2 diabetes mellitus	7.29e-05	0.000598	CcSEcCtD
Acebutolol—Paraesthesia—Losartan—type 2 diabetes mellitus	7.24e-05	0.000593	CcSEcCtD
Acebutolol—Urticaria—Metformin—type 2 diabetes mellitus	7.21e-05	0.000591	CcSEcCtD
Acebutolol—Chest pain—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000591	CcSEcCtD
Acebutolol—Myalgia—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000591	CcSEcCtD
Acebutolol—Arthralgia—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000591	CcSEcCtD
Acebutolol—Dyspnoea—Losartan—type 2 diabetes mellitus	7.19e-05	0.000589	CcSEcCtD
Acebutolol—Anxiety—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000589	CcSEcCtD
Acebutolol—Nausea—Glyburide—type 2 diabetes mellitus	7.18e-05	0.000588	CcSEcCtD
Acebutolol—Abdominal pain—Metformin—type 2 diabetes mellitus	7.18e-05	0.000588	CcSEcCtD
Acebutolol—Dizziness—Gliclazide—type 2 diabetes mellitus	7.17e-05	0.000588	CcSEcCtD
Acebutolol—Somnolence—Losartan—type 2 diabetes mellitus	7.17e-05	0.000588	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000587	CcSEcCtD
Acebutolol—Asthenia—Valsartan—type 2 diabetes mellitus	7.15e-05	0.000586	CcSEcCtD
Acebutolol—Discomfort—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000584	CcSEcCtD
Acebutolol—Dyspepsia—Losartan—type 2 diabetes mellitus	7.1e-05	0.000582	CcSEcCtD
Acebutolol—Asthenia—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000579	CcSEcCtD
Acebutolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.000579	CcSEcCtD
Acebutolol—Pruritus—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000578	CcSEcCtD
Acebutolol—Decreased appetite—Losartan—type 2 diabetes mellitus	7.01e-05	0.000575	CcSEcCtD
Acebutolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7e-05	0.000574	CcSEcCtD
Acebutolol—Confusional state—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000571	CcSEcCtD
Acebutolol—Pruritus—Orlistat—type 2 diabetes mellitus	6.97e-05	0.000571	CcSEcCtD
Acebutolol—Fatigue—Losartan—type 2 diabetes mellitus	6.95e-05	0.00057	CcSEcCtD
Acebutolol—Oedema—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000567	CcSEcCtD
Acebutolol—Vomiting—Gliclazide—type 2 diabetes mellitus	6.9e-05	0.000566	CcSEcCtD
Acebutolol—Pain—Losartan—type 2 diabetes mellitus	6.89e-05	0.000565	CcSEcCtD
Acebutolol—Constipation—Losartan—type 2 diabetes mellitus	6.89e-05	0.000565	CcSEcCtD
Acebutolol—Rash—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.000561	CcSEcCtD
Acebutolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.83e-05	0.00056	CcSEcCtD
Acebutolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.82e-05	0.000559	CcSEcCtD
Acebutolol—Urticaria—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000558	CcSEcCtD
Acebutolol—Shock—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000558	CcSEcCtD
Acebutolol—Headache—Gliclazide—type 2 diabetes mellitus	6.8e-05	0.000557	CcSEcCtD
Acebutolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000556	CcSEcCtD
Acebutolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000555	CcSEcCtD
Acebutolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000555	CcSEcCtD
Acebutolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.74e-05	0.000553	CcSEcCtD
Acebutolol—Skin disorder—Ramipril—type 2 diabetes mellitus	6.71e-05	0.00055	CcSEcCtD
Acebutolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000548	CcSEcCtD
Acebutolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.64e-05	0.000545	CcSEcCtD
Acebutolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.59e-05	0.00054	CcSEcCtD
Acebutolol—Dizziness—Valsartan—type 2 diabetes mellitus	6.59e-05	0.00054	CcSEcCtD
Acebutolol—Anorexia—Ramipril—type 2 diabetes mellitus	6.59e-05	0.00054	CcSEcCtD
Acebutolol—Dizziness—Orlistat—type 2 diabetes mellitus	6.51e-05	0.000534	CcSEcCtD
Acebutolol—Asthenia—Metformin—type 2 diabetes mellitus	6.51e-05	0.000534	CcSEcCtD
Acebutolol—Hypotension—Ramipril—type 2 diabetes mellitus	6.46e-05	0.00053	CcSEcCtD
Acebutolol—Nausea—Gliclazide—type 2 diabetes mellitus	6.44e-05	0.000528	CcSEcCtD
Acebutolol—Pruritus—Metformin—type 2 diabetes mellitus	6.42e-05	0.000527	CcSEcCtD
Acebutolol—Urticaria—Losartan—type 2 diabetes mellitus	6.4e-05	0.000525	CcSEcCtD
Acebutolol—Body temperature increased—Losartan—type 2 diabetes mellitus	6.37e-05	0.000522	CcSEcCtD
Acebutolol—Abdominal pain—Losartan—type 2 diabetes mellitus	6.37e-05	0.000522	CcSEcCtD
Acebutolol—Vomiting—Valsartan—type 2 diabetes mellitus	6.34e-05	0.00052	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000516	CcSEcCtD
Acebutolol—Propranolol—CYP3A4—type 2 diabetes mellitus	6.29e-05	0.0306	CrCbGaD
Acebutolol—Rash—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000515	CcSEcCtD
Acebutolol—Dermatitis—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000515	CcSEcCtD
Acebutolol—Vomiting—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000513	CcSEcCtD
Acebutolol—Insomnia—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000513	CcSEcCtD
Acebutolol—Headache—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000512	CcSEcCtD
Acebutolol—Diarrhoea—Metformin—type 2 diabetes mellitus	6.21e-05	0.000509	CcSEcCtD
Acebutolol—Rash—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000509	CcSEcCtD
Acebutolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000509	CcSEcCtD
Acebutolol—Dermatitis—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000509	CcSEcCtD
Acebutolol—Headache—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000506	CcSEcCtD
Acebutolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000505	CcSEcCtD
Acebutolol—Asthenia—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000504	CcSEcCtD
Acebutolol—Somnolence—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000504	CcSEcCtD
Acebutolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000499	CcSEcCtD
Acebutolol—Pruritus—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000497	CcSEcCtD
Acebutolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000493	CcSEcCtD
Acebutolol—Dizziness—Metformin—type 2 diabetes mellitus	6e-05	0.000492	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000489	CcSEcCtD
Acebutolol—Fatigue—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000489	CcSEcCtD
Acebutolol—Nausea—Valsartan—type 2 diabetes mellitus	5.92e-05	0.000485	CcSEcCtD
Acebutolol—Constipation—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000485	CcSEcCtD
Acebutolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000481	CcSEcCtD
Acebutolol—Nausea—Orlistat—type 2 diabetes mellitus	5.85e-05	0.00048	CcSEcCtD
Acebutolol—Asthenia—Losartan—type 2 diabetes mellitus	5.78e-05	0.000474	CcSEcCtD
Acebutolol—Vomiting—Metformin—type 2 diabetes mellitus	5.77e-05	0.000473	CcSEcCtD
Acebutolol—Rash—Metformin—type 2 diabetes mellitus	5.72e-05	0.000469	CcSEcCtD
Acebutolol—Dermatitis—Metformin—type 2 diabetes mellitus	5.72e-05	0.000469	CcSEcCtD
Acebutolol—Pruritus—Losartan—type 2 diabetes mellitus	5.7e-05	0.000468	CcSEcCtD
Acebutolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000467	CcSEcCtD
Acebutolol—Headache—Metformin—type 2 diabetes mellitus	5.69e-05	0.000466	CcSEcCtD
Acebutolol—Dizziness—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000464	CcSEcCtD
Acebutolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.65e-05	0.000463	CcSEcCtD
Acebutolol—Diarrhoea—Losartan—type 2 diabetes mellitus	5.52e-05	0.000452	CcSEcCtD
Acebutolol—Urticaria—Ramipril—type 2 diabetes mellitus	5.49e-05	0.00045	CcSEcCtD
Acebutolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000448	CcSEcCtD
Acebutolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000448	CcSEcCtD
Acebutolol—Vomiting—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000447	CcSEcCtD
Acebutolol—Rash—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000443	CcSEcCtD
Acebutolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000442	CcSEcCtD
Acebutolol—Nausea—Metformin—type 2 diabetes mellitus	5.39e-05	0.000442	CcSEcCtD
Acebutolol—Headache—Irbesartan—type 2 diabetes mellitus	5.37e-05	0.00044	CcSEcCtD
Acebutolol—Dizziness—Losartan—type 2 diabetes mellitus	5.33e-05	0.000437	CcSEcCtD
Acebutolol—Vomiting—Losartan—type 2 diabetes mellitus	5.13e-05	0.00042	CcSEcCtD
Acebutolol—Nausea—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000417	CcSEcCtD
Acebutolol—Rash—Losartan—type 2 diabetes mellitus	5.08e-05	0.000417	CcSEcCtD
Acebutolol—Dermatitis—Losartan—type 2 diabetes mellitus	5.08e-05	0.000416	CcSEcCtD
Acebutolol—Headache—Losartan—type 2 diabetes mellitus	5.05e-05	0.000414	CcSEcCtD
Acebutolol—Asthenia—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000407	CcSEcCtD
Acebutolol—Pruritus—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000401	CcSEcCtD
Acebutolol—Nausea—Losartan—type 2 diabetes mellitus	4.79e-05	0.000393	CcSEcCtD
Acebutolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000388	CcSEcCtD
Acebutolol—Dizziness—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000375	CcSEcCtD
Acebutolol—Vomiting—Ramipril—type 2 diabetes mellitus	4.39e-05	0.00036	CcSEcCtD
Acebutolol—Rash—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000357	CcSEcCtD
Acebutolol—Dermatitis—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000357	CcSEcCtD
Acebutolol—Headache—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000355	CcSEcCtD
Acebutolol—Nausea—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000337	CcSEcCtD
Acebutolol—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.59e-06	0.00021	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	8.59e-06	0.00021	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.56e-06	0.000209	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.5e-06	0.000207	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	8.49e-06	0.000207	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	8.44e-06	0.000206	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.32e-06	0.000203	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.26e-06	0.000201	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	8.24e-06	0.000201	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.24e-06	0.000201	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.2e-06	0.0002	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	8.15e-06	0.000199	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	8.15e-06	0.000199	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	8.15e-06	0.000199	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	8.15e-06	0.000199	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	8.1e-06	0.000198	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.1e-06	0.000198	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.06e-06	0.000197	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.02e-06	0.000196	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.97e-06	0.000194	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	7.95e-06	0.000194	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.94e-06	0.000194	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.92e-06	0.000193	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.92e-06	0.000193	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	7.81e-06	0.000191	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.79e-06	0.00019	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.77e-06	0.000189	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	7.68e-06	0.000187	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	7.68e-06	0.000187	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	7.68e-06	0.000187	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	7.68e-06	0.000187	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.58e-06	0.000185	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.45e-06	0.000182	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.45e-06	0.000182	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.44e-06	0.000181	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.41e-06	0.000181	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	7.4e-06	0.000181	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.4e-06	0.000181	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	7.37e-06	0.00018	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	7.36e-06	0.00018	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.28e-06	0.000178	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.28e-06	0.000177	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	7.27e-06	0.000177	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	7.26e-06	0.000177	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	7.06e-06	0.000172	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.04e-06	0.000172	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.99e-06	0.00017	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.98e-06	0.00017	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.89e-06	0.000168	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.89e-06	0.000168	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.89e-06	0.000168	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.87e-06	0.000168	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.86e-06	0.000167	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.84e-06	0.000167	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.83e-06	0.000167	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.83e-06	0.000166	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.78e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.75e-06	0.000165	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	6.74e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.74e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.74e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.71e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.68e-06	0.000163	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.65e-06	0.000162	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.64e-06	0.000162	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.64e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.63e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.61e-06	0.000161	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.6e-06	0.000161	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	6.58e-06	0.00016	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.55e-06	0.00016	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.51e-06	0.000159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.51e-06	0.000159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.48e-06	0.000158	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.47e-06	0.000158	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.47e-06	0.000158	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.47e-06	0.000158	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.43e-06	0.000157	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.41e-06	0.000156	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	6.4e-06	0.000156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	6.39e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.35e-06	0.000155	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.32e-06	0.000154	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.32e-06	0.000154	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.26e-06	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.26e-06	0.000153	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.25e-06	0.000152	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.22e-06	0.000152	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.22e-06	0.000152	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.14e-06	0.00015	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.13e-06	0.00015	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.1e-06	0.000149	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.1e-06	0.000149	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.1e-06	0.000149	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.09e-06	0.000148	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	6.07e-06	0.000148	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.06e-06	0.000148	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.96e-06	0.000145	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.95e-06	0.000145	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	5.95e-06	0.000145	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.89e-06	0.000144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.85e-06	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.83e-06	0.000142	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.81e-06	0.000142	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.81e-06	0.000142	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.81e-06	0.000142	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	5.77e-06	0.000141	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.73e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	5.72e-06	0.00014	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.7e-06	0.000139	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	5.65e-06	0.000138	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.65e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	5.6e-06	0.000137	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	5.59e-06	0.000136	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.53e-06	0.000135	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.47e-06	0.000133	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.47e-06	0.000133	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.47e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.46e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.44e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.44e-06	0.000133	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.37e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.35e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.34e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.33e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.33e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.31e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.27e-06	0.000128	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.25e-06	0.000128	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.25e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.23e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.21e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.21e-06	0.000127	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.21e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.15e-06	0.000126	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.12e-06	0.000125	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.03e-06	0.000123	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.03e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.02e-06	0.000123	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5e-06	0.000122	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	4.92e-06	0.00012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.91e-06	0.00012	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	4.83e-06	0.000118	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.83e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.75e-06	0.000116	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.74e-06	0.000116	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.74e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.65e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.48e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	4.45e-06	0.000109	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	4.42e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.4e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.4e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.38e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.38e-06	0.000107	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.34e-06	0.000106	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.34e-06	0.000106	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.32e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.31e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.3e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.28e-06	0.000105	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.26e-06	0.000104	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.18e-06	0.000102	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.14e-06	0.000101	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.09e-06	9.97e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.09e-06	9.97e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.09e-06	9.97e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.07e-06	9.93e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.02e-06	9.82e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.02e-06	9.8e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.99e-06	9.73e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.99e-06	9.73e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.95e-06	9.64e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.9e-06	9.52e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.9e-06	9.52e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.9e-06	9.51e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.87e-06	9.44e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.87e-06	9.43e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.85e-06	9.4e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.79e-06	9.25e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.76e-06	9.16e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.75e-06	9.16e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.72e-06	9.08e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.71e-06	9.04e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.67e-06	8.96e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.64e-06	8.89e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.63e-06	8.86e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.56e-06	8.68e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.54e-06	8.63e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.49e-06	8.52e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.49e-06	8.51e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.42e-06	8.34e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.39e-06	8.26e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.38e-06	8.24e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.37e-06	8.21e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.35e-06	8.18e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.34e-06	8.16e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.32e-06	8.11e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.31e-06	8.08e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.31e-06	8.08e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.29e-06	8.03e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.29e-06	8.02e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.27e-06	7.99e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.2e-06	7.81e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.18e-06	7.77e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.17e-06	7.73e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.13e-06	7.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.13e-06	7.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.12e-06	7.61e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.11e-06	7.57e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.1e-06	7.56e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.08e-06	7.52e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.04e-06	7.41e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.95e-06	7.2e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.89e-06	7.04e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.88e-06	7.04e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.87e-06	7.01e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.83e-06	6.9e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.81e-06	6.86e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	6.63e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	6.5e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.64e-06	6.44e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.59e-06	6.33e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.59e-06	6.31e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.58e-06	6.3e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.53e-06	6.17e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	6.05e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	6.05e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.44e-06	5.96e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	5.7e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	5.7e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	5.53e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	5.22e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.99e-06	4.85e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.95e-06	4.75e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.94e-06	4.74e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.83e-06	4.47e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.79e-06	4.38e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	2.78e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	2.62e-05	CbGpPWpGaD
